Differential effects of intrastriatal and intranigral injections of glutamate antagonists on motor behaviour in the reserpine-treated rat

被引:41
作者
Kaur, S [1 ]
Starr, MS [1 ]
机构
[1] UNIV LONDON,DEPT PHARMACOL,SCH PHARM,LONDON WC1N 1AX,ENGLAND
关键词
glutamate; reserpine; rat; substantia nigra pars reticulata; NMDA; AMPA;
D O I
10.1016/S0306-4522(96)00407-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A variety of N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonists, and the antiepileptic drug lamotrigine, were examined for their ability to restore locomotion and other behaviours when injected stereotaxically via indwelling cannulae into the striatum or substantia nigra pars reticulata of rats rendered akinetic with reserpine (5 mg/kg i.p. 24 h beforehand). Only the competitive N-methyl-D-aspartate antagonists 3-((+)-2-carboxppiperazin-4-yl)-propyl-1-phosphonate and R-DL-(E)-2-amino-3-methyl-5-phosphono-3-pentanoate stimulated locomotion from the striatum, whereas 2-amino-phosphonopentanoic acid, the N-methyl-D-aspartate channel blockers dizocilpine maleate and phencyclidine, and the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid antagonist 2,3-dihydroxy-6-nitro-7-sulphamoyl-benzo(f)-quinoxaline-kione, were additionally effective in the substantia nigra pars reticulata. The N-methyl-D-aspartate glycine site antagonist (RS)-3-amino-1-hydroxypyrrolidin-2-one and the glutamate release inhibitor lamotrigine failed to restore locomotion at these sites, and the N-methyl-D-aspartate polyamine site antagonist eliprodil was ineffective in the substantia nigra pars reticulata, although all compounds tested (except lamotrigine) induced orofacial, head and/or limb movements to some degree. Except For 2,3-dihydroxy-6-nitro-7-sulphamoyl-benzo(f)-quinoxaline-dione, locomotion was accompanied dose-dependently by increasingly pronounced ataxia and postural abnormalities. These results show that the monoamine-depleted substantia nigra pars reticulata has a broader spectrum of responsitivity to the antiparkinsonian actions of N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid antagonists than does the striatum, and that the harmful as well as the beneficial effects of these compounds on locomotion arise from these two structures. Copyright (C) 1996 IBRO.
引用
收藏
页码:345 / 354
页数:10
相关论文
共 64 条
[1]   THE FUNCTIONAL-ANATOMY OF BASAL GANGLIA DISORDERS [J].
ALBIN, RL ;
YOUNG, AB ;
PENNEY, JB .
TRENDS IN NEUROSCIENCES, 1989, 12 (10) :366-375
[2]   EXCITATORY AMINO-ACID BINDING-SITES IN THE BASAL GANGLIA OF THE RAT - A QUANTITATIVE AUTORADIOGRAPHIC STUDY [J].
ALBIN, RL ;
MAKOWIEC, RL ;
HOLLINGSWORTH, ZR ;
DURE, LS ;
PENNEY, JB ;
YOUNG, AB .
NEUROSCIENCE, 1992, 46 (01) :35-48
[3]   FELINE SUBTHALAMIC NUCLEUS NEURONS CONTAIN GLUTAMATE-LIKE BUT NOT GABA-LIKE OR GLYCINE-LIKE IMMUNOREACTIVITY [J].
ALBIN, RL ;
ALDRIDGE, JW ;
YOUNG, AB ;
GILMAN, S .
BRAIN RESEARCH, 1989, 491 (01) :185-188
[4]   THE BEHAVIORAL-EFFECTS OF MK-801 INJECTED INTO NUCLEUS-ACCUMBENS AND CAUDATE-PUTAMEN OF RATS [J].
ALKHATIB, I ;
KARADAG, HC ;
ULUGOL, A .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1995, 52 (04) :723-730
[5]   REVERSAL OF EXPERIMENTAL PARKINSONISM BY LESIONS OF THE SUBTHALAMIC NUCLEUS [J].
BERGMAN, H ;
WICHMANN, T ;
DELONG, MR .
SCIENCE, 1990, 249 (4975) :1436-1438
[6]   Motor actions of eliprodil in the normal and monoamine-depleted mouse: A role in the treatment of Parkinson's disease? [J].
Brooks, S ;
Kaur, S ;
Starr, BS ;
Starr, MS .
JOURNAL OF NEURAL TRANSMISSION, 1996, 103 (06) :737-748
[7]   ALLEVIATION OF PARKINSONISM BY ANTAGONISM OF EXCITATORY AMINO-ACID TRANSMISSION IN THE MEDIAL SEGMENT OF THE GLOBUS-PALLIDUS IN RAT AND PRIMATE [J].
BROTCHIE, JM ;
MITCHELL, IJ ;
SAMBROOK, MA ;
CROSSMAN, AR .
MOVEMENT DISORDERS, 1991, 6 (02) :133-138
[8]  
CARLSSON ML, 1993, J NEURAL TRANSM, V75, P221
[9]   NEUROCHEMICAL AND BEHAVIORAL INVESTIGATIONS OF THE NMDA RECEPTOR-ASSOCIATED GLYCINE SITE IN THE RAT STRIATUM - FUNCTIONAL IMPLICATIONS FOR TREATMENT OF PARKINSONIAN SYMPTOMS [J].
CARROLL, CB ;
HOLLOWAY, V ;
BROTCHIE, JM ;
MITCHELL, IJ .
PSYCHOPHARMACOLOGY, 1995, 119 (01) :55-65